GlassScriptPhysician profile
Olga Konykhov
NPI 1245375880
$2,355.11
in general payments reported to CMS, 2019-2025
19 companies · $760 in 2025
The $760 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $30.09 · 2021: $217 · 2022: $348 · 2023: $355 · 2024: $504 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,618.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $411.87 | 2019-2025 | Rocklatan, Hydrus Microstent, Clareon |
| Bausch & Lomb Americas INC. | $310.90 | 2022-2025 | Xiidra, Vyzulta, Prolensa |
| Sun Pharmaceutical Industries INC. | $278.72 | 2019-2025 | Cequa |
| Abbvie INC. | $261.69 | 2022-2025 | |
| Dompe US, INC. | $203.23 | 2021-2025 | Oxervate |
| Harrow Eye, LLC | $162.68 | 2024-2025 | Tobradex St, Natacyn, Vevye |
| Tarsus Pharmaceuticals, INC. | $119.50 | 2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $106.58 | 2021-2023 | |
| Allergan, INC. | $94.68 | 2020-2021 | |
| Oyster Point Pharma, INC. | $84.87 | 2022-2025 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $65.49 | 2020-2025 | Tecnis Iol, Tecnis Iol |
| Amgen INC. | $53.16 | 2024-2025 | Tepezza |
| Rxsight INC | $43.94 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Kala Pharmaceuticals, INC. | $41.48 | 2019-2021 | |
| Ocular Therapeutix, INC. | $32.86 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $23.70 | 2024 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.95 | 2019 | |
| Aerie Pharmaceuticals, INC. | $21.02 | 2021 | |
| Horizon Therapeutics Plc | $15.79 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Konykhov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.